STEEP HILL TERMINATES LICENSE AGREEMENTS WITH PAZOO AND AFFILIATES

Licenses Previously Granted To Pazoo Subsidiaries To Open Labs In Colorado, Nevada And Oregon Have Been Revoked

July 1, 2016 – Berkeley, CA – Steep Hill Labs, Inc., the global leader in cannabis genetics, analytics and testing, today announced it has terminated all Licensee Agreements with Pazoo, Inc. (OTCMKTS:PZOO) and its subsidiaries, effective immediately.  This termination includes the licenses previously granted to Pazoo and its subsidiaries to open and run Steep Hill branded labs in the states of Colorado, Nevada and Oregon.

This termination is based upon the failure of Pazoo and its subsidiaries to meet their contractual obligations. We will turn this disappointing and unproductive relationship into a new opportunity to seek licensee partners in these rapidly evolving states that can get licensed and start testing using Steep Hill’s leading science and technology platforms.

Steep Hill President and CEO Jmîchaeĺe Keller

The industry is undergoing accelerated change,  and Steep Hill’s licensing program is rapidly changing as well.  Due to these changes, we have become more selective with whom we choose to partner, and we are excited about a new beginning in these states.

ABOUT STEEP HILL

Founded in California in 2008, Steep Hill Labs, Inc. is a science and technology firm that has become the global leader in cannabis genetics, analytics and testing.  With company owned labs in California, Washington and New Mexico and two new licensees in Maryland and Alaska launching in 2016, along with a joint venture in Jamaica—Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California—the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™, GenKit™ and Steep Hill Express™.  Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well.

Contact:

Cathie Bennett Warner
cell: 415-420-1573
cathie@steephill.com

Source: Steep Hill

Published by NCV Newswire

The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.